Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Stevens

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Annals of Hematology|December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensL E M Oosten, M E D Chamuleau, F W Thielen, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma RecurrencesMadeleine R Berendsen, Diede A G van Bladel, Eva Hesius, et al.
Hemasphere|April 11, 2023
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred TreatmentWendy B C Stevens, G Tjitske Los-de Vries, Carole Langois-Jacques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
The Lancet. Haematology|November 3, 2023
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trialMartine E D Chamuleau, Frank Stenner, Dana A Chitu, et al.
Blood Advances|August 8, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphomaDiede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Annals of Hematology|December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensL E M Oosten, M E D Chamuleau, F W Thielen, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma RecurrencesMadeleine R Berendsen, Diede A G van Bladel, Eva Hesius, et al.
Hemasphere|April 11, 2023
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred TreatmentWendy B C Stevens, G Tjitske Los-de Vries, Carole Langois-Jacques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
The Lancet. Haematology|November 3, 2023
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trialMartine E D Chamuleau, Frank Stenner, Dana A Chitu, et al.
Blood Advances|August 8, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphomaDiede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, et al.
Pageof 6